Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |